Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-078573 and desipramine drug-drug interaction crossover study in healthy male volunteers
NL-OMON32097Not yet recruiting
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of almorexant and desipramine in Insomnia (2 arms), sponsored by Actelion Pharmaceuticals Ltd. Primary endpoints: Maximum concentration (Cmax) of desipramine and Area under the plasma concentration-time curve from zero to infinity (AUC0-inf) of desipramine. Planned start Jun 2008; status: not yet recruiting.
02
Drugs
almorexantdesipramine
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON32097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32097.